Advanced Bionics agrees to pay more than $12 million to the federal government and participating Medicaid states to resolve a whistleblowers suit alle...
FDA approves an On Target Laboratories supplemental NDA for Cytalux (pafolacianine) to help surgeons in identifying lung cancer lesions.
FDA approves a Ferring Pharmaceuticals BLA for Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating adenoviral vector‑based gene thera...
FDA says it is holding a 1/26/2023 meeting of its Vaccines and Related Biological Products Advisory Committee to consider whether current Covid-19 vac...
Congress passes S 3905 Preventing Organizational Conflicts of Interest in Federal Acquisition Act that aims to curb government contractors from having...
Federal Register notice: FDA corrects an 8/20 notice to reflect the correct dates that the support and requirement were to begin for version 1.7 of th...
Federal Register notice: FDA makes available a draft guidance entitled Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug o...
FDA issues a draft update to guidance for industry #152, Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological ...
